- Home
- MOBX vs HOOK Comparison
MOBX vs HOOK Comparison
Compare MOBX & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- HOOK
- Stock Information
- Founded
- MOBX 2020
- HOOK 2011
- Country
- MOBX United States
- HOOK United States
- Employees
- MOBX N/A
- HOOK N/A
- Industry
- MOBX
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- MOBX
- HOOK Health Care
- Exchange
- MOBX Nasdaq
- HOOK Nasdaq
- Market Cap
- MOBX 29.9M
- HOOK 25.8M
- IPO Year
- MOBX N/A
- HOOK 2019
- Fundamental
- Price
- MOBX $1.87
- HOOK $2.02
- Analyst Decision
- MOBX
- HOOK Buy
- Analyst Count
- MOBX 0
- HOOK 4
- Target Price
- MOBX N/A
- HOOK $23.00
- AVG Volume (30 Days)
- MOBX 2.2M
- HOOK 64.0K
- Earning Date
- MOBX 12-19-2024
- HOOK 11-14-2024
- Dividend Yield
- MOBX N/A
- HOOK N/A
- EPS Growth
- MOBX N/A
- HOOK N/A
- EPS
- MOBX N/A
- HOOK N/A
- Revenue
- MOBX $3,921,000.00
- HOOK $49,999,000.00
- Revenue This Year
- MOBX N/A
- HOOK $147.52
- Revenue Next Year
- MOBX N/A
- HOOK N/A
- P/E Ratio
- MOBX N/A
- HOOK N/A
- Revenue Growth
- MOBX 214.69
- HOOK 143.30
- 52 Week Low
- MOBX $0.55
- HOOK $1.88
- 52 Week High
- MOBX $12.47
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- MOBX 65.49
- HOOK 29.47
- Support Level
- MOBX $0.96
- HOOK $1.96
- Resistance Level
- MOBX $1.30
- HOOK $2.18
- Average True Range (ATR)
- MOBX 0.35
- HOOK 0.20
- MACD
- MOBX 0.09
- HOOK 0.02
- Stochastic Oscillator
- MOBX 61.81
- HOOK 19.44
About MOBX Mobix Labs Inc.
Mobix Labs Inc is a fabless semiconductor company developing disruptive next generation wireless and connected solutions that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive, consumer electronics, e-mobility, healthcare, infrastructure and defense.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.